Green tea supplementation ameliorates insulin resistance and increases glucose transporter IV content in a fructose-fed rat model.
Level 5 - mechanism / opinion, no new human data
Animal experiment without human participants
PubMed 15083319 · doi:10.1007/s00394-004-0450-x
What was done
Sprague-Dawley rats were divided into three groups for 12 weeks: standard chow with water (control), high-fructose diet with water, or high-fructose diet with green tea (0.5 g lyophilized green tea powder dissolved in 100 mL deionized distilled water daily). Blood pressure was measured twice weekly, and an oral glucose tolerance test was performed at 12 weeks. Plasma triglycerides, free fatty acids, glucose, and insulin were measured. Epididymal fat pads from each group were pooled to isolate adipocytes and assess insulin binding, glucose uptake, and GLUT I and GLUT IV contents.
What was found
No numerical values or effect sizes were reported in the abstract. Compared to controls, fructose-fed rats developed fasting hyperglycemia, hyperinsulinemia, elevated blood pressure, reduced adipocyte insulin binding, decreased insulin-stimulated glucose uptake, and decreased GLUT IV content. Green tea supplementation improved all of these metabolic defects, including insulin resistance and blood pressure.
Why it matters
This study provides mechanistic evidence that green tea's potential metabolic benefits in diet-induced insulin resistance may be linked to the preservation or upregulation of adipose GLUT IV expression.
Limits
This is a preclinical rodent study and cannot establish efficacy or safety in humans. The abstract omits sample sizes (n per group) and all quantitative metrics. Fat pads were pooled by group rather than analyzed per animal, preventing measurement of within-group variance for cellular assays.
Cited by
- supports Chronic feeding of fructose to animals induces severe insulin resistance, resulting in elevated glucose and high insulin levels.